Cyberlux 2020 annual report

NOTE I - GOING CONCERN MATTERS The accompanying statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the accompanying consolidated financial statements, as of December 31, 2020, the Company incurred accumulated losses of $ 32,315,198. The Company’s current liabilities exceeded its current assets by $4,642,873 as of December 31, 2020. While this factors among others may indicate that the Company will be unable t o continue as a going concern, Management is confident that business performance in 2022 will ensure the Company is an ongoing growth business for the foreseeable future. The Company is actively pursuing additional business growth across four distinct bus iness units through acquisitions, organic growth and new customers and product that will increase the associated cash flow from operations. However, no assurance can be given that Management's actions will result in profitable operations or the of its liquidity problems. NOTE J - SUBSEQUENT EVENTS Management has determined that no significant subsequent events occurred since the balance sheet date. NOTE K - CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE None. NOTE L - CONTROLS AND PROCEDURES Evaluation of Disclosure Controls and Procedures The Company’s management, under the supervision of the Company’s Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the eff ectiveness of the design and operation of our disclosure controls and procedures. Disclosure controls and procedures mean our controls and other procedures that are designed to ensure that information required to be disclosed in the reports that we file or submit is recorded, processed, summarized and reported within the time periods required. Disclosure controls and procedures are also designed to provide reasonable assurance that such information is accumulated and communicated to our management, including the chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure. Our quarterly evaluation of disclosure controls and procedures includes an evaluation of some components of our internal control over financial reporting, and internal control over financial reporting is also separately evaluated on an annual basis for purposes of providing the management report that is set forth below. At the same time our disclosure controls and procedures can identify weaknesses in our financial reporting and control systems that require remediated action. The evaluation conducted included the design, as well as the implementation, of the disclosure controls and procedures, and how the output produced was us ed in the preparation of this Annual Report. In the course of performing this evaluation, particular attention was paid to identifying past, present and potential occurrences of data errors, problems of control, and the potential for fraud. Our Chief Executive Officer and Chief Financial Officer have concluded, based on the evaluation of the effectiveness of the disclosure controls and procedures by our management, that as of December 31, 2020 our disclosure controls and procedures were effective. Management’s Report on Internal Control over Financial Reporting Our management is responsible for the establishment and maintenance of an adequate system of internal controls over financial reporting. Internal control over financial reporting is a process design ed by, or under the supervision of, our

Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines Cyberlux Corporation 800 Park Offices Drive, Suite 3209 Research Triangle, NC 27709 984-363-6894 www.cyberlux.com info@cyberlux.com 3674 Annual Report For the Period Ending: December 31, 2020 (the “Reporting Period”) As of December 31, 2020, the number of shares outstanding of our Common Stock was: 4,481,275,578 As of September 30, 2020, the number of shares outstanding of our Common Stock was: 4,481,275,578 As of December 31, 2019, the number of shares outstanding of our Common Stock was: 4,481,275,578 Indicate by check mark whether the company is a shell company (as defined in Rule 405 of the Securities Act of 1933 and Rule 12b-2 of the Exchange Act of 1934): Yes: ☐ No: ☒ Indicate by check mark whether the company’s shell status has changed since the previous reporting period: Yes: ☐ No: ☒ Indicate by check mark whether a Change in Control1 of the company has occurred over this reporting period: Yes: ☐ No: ☒ 1) Name and address(es) of the issuer and its predecessors (if any) Cyberlux Corporation (the “Company”) was incorporated under the laws of the State of Nevada on May 17, 2000. Until December 31, 2004, the Company was a development stage enterprise as defined under Accounting Standards Codification 1 “Change in Control” shall mean any events resulting in: (i) Any “person” (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becoming the “beneficial owner” (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company’s then outstanding voting securities; (ii) The consummation of the sale or disposition by the Company of all or substantially all of the C ompany’s assets; (iii) A change in the composition of the Board occurring within a two (2) -year period, as a result of which fewer than a majority of the directors are directors immediately prior to such change; or (iv) The consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation.

Condensed Consolidated Balance Sheet Fiscal Year Ended December 31, 2020 and December 31, 2019 (Unaudited) December 31, 2020 December 31, 2019 Assets Current assets: Cash & cash equivalents $ - $ 31 Investment - restricted use - 63 Accounts Receivable, Allowance for Doubtful Accounts is $ 0 - - Inventory 78,838 78,838 Other current assets - - Total current assets 78,838 78,932 Property, plant and equipment, net of accumulated depreciation of $ 92,631 and $ 92,631 respectively - - Other Assets: Patents, net of accumulated amortization of $ 3,974,974 and $3,974,974 respectively - - Total Assets $ 78,838 $ 78,932 Liabilities and Deficiency in Stockholders' Equity Current liabilities: Accounts payable 1,081,962 989,209 Accrued interest 1,431,345 1,153,300 Accrued liabilities 2,208,404 2,742,322 Warrants payable - - Total current liabilities 4,721,711 4,884,831 Long-term liabilities: Notes payable, related parties 3,215,143 2,822,161 Notes payable, non-related parties 2,203,354 5,279,538 Total long-term liabilities 5,418,498 8,101,700 Deficiency Stockholders' equity: Preferred stock, $0.001 par value, 100,000,000 shares authorized Class A Preferred, 26.9806 and 26.9806 shares issued and outstanding as of December 31, 2020 and December 31, 2019 respectively 134,900 134,900

Par or stated value: $0.001 Total shares authorized: 200 as of date: December 31, 2020 Total shares outstanding: 26.9806 as of date: December 31, 2020 Total number of shareholders of record: 7 as of date: December 31, 2020 Trading symbol: CYBL Exact title and class of securities outstanding: Preferred Stock – Class B CUSIP: NA Par or stated value: $0.001 Total shares authorized: 100,000,000 as of date: December 31, 2020 Total shares outstanding: 100,000,000 as of date: December 31, 2020 Total number of shareholders of record: 3 as of date: December 31, 2020 Trading symbol: CYBL Exact title and class of securities outstanding: Preferred Stock – Class C CUSIP: NA Par or stated value: $0.001 Total shares authorized: 150,000 as of date: December 31, 2020 Total shares outstanding: 150,000 as of date: December 31, 2020 Total number of shareholders of record: 2 as of date: December 31, 2020 Transfer Agent Name: Standard Registrar and Transfer Company, Inc. Phone: 801-571-8844 Email: amy@standardregistrar.com Address: 440 E 400 S Suite 200, Salt Lake City, UT 84111 Is the Transfer Agent registered under the Exchange Act? 3 Yes: ☒ No: ☐ 3) Issuance History The goal of this section is to provide disclosure with respect to each event that resulted in any direct changes to the total shares outstanding of any class of the issuer’s securities in the past two completed fiscal years and any subsequent interim period. Disclosure under this item shall include, in chronological order, all offerings and issuances of securities, including debt convertible into equity securities, whether private or public, and all shares, or any other securities or options to acquire such securities, issued for services. Using the tabular format below, please describe these events. A. Changes to the Number of Outstanding Shares Check this box to indicate there were no changes to the number of outstanding shares within the past two completed fiscal years and any subsequent periods: ☒ 3 To be included in the Pink Current Information tier, the transfer agent must be registered under the Exchange Act. Shares Outstanding as of Second Most Recent Fiscal Year End: Opening Balance Date 12/31/2018 Common: 4,481,275,578 Preferred: A: 26.9806 B: 100,000,000 C: 150,000 *Right-click the rows below and select “Insert” to add rows as needed.

Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines Cyberlux Corporation 800 Park Offices Drive, Suite 3209 Research Triangle, NC 27709 984-363-6894 www.cyberlux.com info@cyberlux.com 3674 Annual Report For the Period Ending: December 31, 2020 (the “Reporting Period”) As of December 31, 2020, the number of shares outstanding of our Common Stock was: 4,481,275,578 As of September 30, 2020, the number of shares outstanding of our Common Stock was: 4,481,275,578 As of December 31, 2019, the number of shares outstanding of our Common Stock was: 4,481,275,578 Indicate by check mark whether the company is a shell company (as defined in Rule 405 of the Securities Act of 1933 and Rule 12b-2 of the Exchange Act of 1934): Yes: ☐ No: ☒ Indicate by check mark whether the company’s shell status has changed since the previous reporting period: Yes: ☐ No: ☒ Indicate by check mark whether a Change in Control1 of the company has occurred over this reporting period: Yes: ☐ No: ☒ 1) Name and address(es) of the issuer and its predecessors (if any) Cyberlux Corporation (the “Company”) was incorporated under the laws of the State of Nevada on May 17, 2000. Until December 31, 2004, the Company was a development stage enterprise as defined under Accounting Standards Codification 1 “Change in Control” shall mean any events resulting in: (i) Any “person” (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becoming the “beneficial owner” (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company’s then outstanding voting securities; (ii) The consummation of the sale or disposition by the Company of all or substantially all of the C ompany’s assets; (iii) A change in the composition of the Board occurring within a two (2) -year period, as a result of which fewer than a majority of the directors are directors immediately prior to such change; or (iv) The consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation.

Condensed Consolidated Balance Sheet Fiscal Year Ended December 31, 2020 and December 31, 2019 (Unaudited) December 31, 2020 December 31, 2019 Assets Current assets: Cash & cash equivalents $ - $ 31 Investment - restricted use - 63 Accounts Receivable, Allowance for Doubtful Accounts is $ 0 - - Inventory 78,838 78,838 Other current assets - - Total current assets 78,838 78,932 Property, plant and equipment, net of accumulated depreciation of $ 92,631 and $ 92,631 respectively - - Other Assets: Patents, net of accumulated amortization of $ 3,974,974 and $3,974,974 respectively - - Total Assets $ 78,838 $ 78,932 Liabilities and Deficiency in Stockholders' Equity Current liabilities: Accounts payable 1,081,962 989,209 Accrued interest 1,431,345 1,153,300 Accrued liabilities 2,208,404 2,742,322 Warrants payable - - Total current liabilities 4,721,711 4,884,831 Long-term liabilities: Notes payable, related parties 3,215,143 2,822,161 Notes payable, non-related parties 2,203,354 5,279,538 Total long-term liabilities 5,418,498 8,101,700 Deficiency Stockholders' equity: Preferred stock, $0.001 par value, 100,000,000 shares authorized Class A Preferred, 26.9806 and 26.9806 shares issued and outstanding as of December 31, 2020 and December 31, 2019 respectively 134,900 134,900

Condensed Consolidated Balance Sheet Fiscal Year Ended December 31, 2020 and December 31, 2019 (Unaudited) December 31, 2020 December 31, 2019 Assets Current assets: Cash & cash equivalents $ - $ 31 Investment - restricted use - 63 Accounts Receivable, Allowance for Doubtful Accounts is $ 0 - - Inventory 78,838 78,838 Other current assets - - Total current assets 78,838 78,932 Property, plant and equipment, net of accumulated depreciation of $ 92,631 and $ 92,631 respectively - - Other Assets: Patents, net of accumulated amortization of $ 3,974,974 and $3,974,974 respectively - - Total Assets $ 78,838 $ 78,932 Liabilities and Deficiency in Stockholders' Equity Current liabilities: Accounts payable 1,081,962 989,209 Accrued interest 1,431,345 1,153,300 Accrued liabilities 2,208,404 2,742,322 Warrants payable - - Total current liabilities 4,721,711 4,884,831 Long-term liabilities: Notes payable, related parties 3,215,143 2,822,161 Notes payable, non-related parties 2,203,354 5,279,538 Total long-term liabilities 5,418,498 8,101,700 Deficiency Stockholders' equity: Preferred stock, $0.001 par value, 100,000,000 shares authorized Class A Preferred, 26.9806 and 26.9806 shares issued and outstanding as of December 31, 2020 and December 31, 2019 respectively 134,900 134,900

Condensed Statements of Consolidated Operations Fiscal Year Ended December 31, 2020 and December 31, 2019 (Unaudited) Year To Date Dec. 31, 2020 Dec. 31, 2019 Revenue - - Cost of goods sold 16,724 - Gross margin (loss) 16,724 - Operating Expenses: Marketing and advertising - - Depreciation and amortization - - Research and development - - General and administrative expenses (106,908) 325,034 Total operating expenses (106,908) 325,034 Income from operations 123,632 (325,034) Other income/(expense) Gain on debt conversion - - Gain/(Loss) on sale of fixed assets - - Interest income - - Interest expense (384,722) (370,774) Other Income 3,107,318 5,250,000 Net income/(loss) before provision for income taxes and preferred dividend 2,846,228 4,554,192 Income taxes (benefit) - - Net income/(loss) available to common stockholders $ 2,846,228 $ 4,554,192 Weighted average number of common shares outstanding, basic 4,481,275,578 4,481,275,578 Loss per share - basic and fully diluted 0.00 0.00 The accompanying notes are an integral part of these financial statements.

Condensed Statements of Consolidated Operations Fiscal Year Ended December 31, 2020 and December 31, 2019 (Unaudited) Year To Date Dec. 31, 2020 Dec. 31, 2019 Revenue - - Cost of goods sold 16,724 - Gross margin (loss) 16,724 - Operating Expenses: Marketing and advertising - - Depreciation and amortization - - Research and development - - General and administrative expenses (106,908) 325,034 Total operating expenses (106,908) 325,034 Income from operations 123,632 (325,034) Other income/(expense) Gain on debt conversion - - Gain/(Loss) on sale of fixed assets - - Interest income - - Interest expense (384,722) (370,774) Other Income 3,107,318 5,250,000 Net income/(loss) before provision for income taxes and preferred dividend 2,846,228 4,554,192 Income taxes (benefit) - - Net income/(loss) available to common stockholders $ 2,846,228 $ 4,554,192 Weighted average number of common shares outstanding, basic 4,481,275,578 4,481,275,578 Loss per share - basic and fully diluted 0.00 0.00 The accompanying notes are an integral part of these financial statements.

Condensed Statements of Consolidated Operations Fiscal Year Ended December 31, 2020 and December 31, 2019 (Unaudited) Year To Date Dec. 31, 2020 Dec. 31, 2019 Revenue - - Cost of goods sold 16,724 - Gross margin (loss) 16,724 - Operating Expenses: Marketing and advertising - - Depreciation and amortization - - Research and development - - General and administrative expenses (106,908) 325,034 Total operating expenses (106,908) 325,034 Income from operations 123,632 (325,034) Other income/(expense) Gain on debt conversion - - Gain/(Loss) on sale of fixed assets - - Interest income - - Interest expense (384,722) (370,774) Other Income 3,107,318 5,250,000 Net income/(loss) before provision for income taxes and preferred dividend 2,846,228 4,554,192 Income taxes (benefit) - - Net income/(loss) available to common stockholders $ 2,846,228 $ 4,554,192 Weighted average number of common shares outstanding, basic 4,481,275,578 4,481,275,578 Loss per share - basic and fully diluted 0.00 0.00 The accompanying notes are an integral part of these financial statements.

Condensed Consolidated Statement of Cash Flow Fiscal Year Ended December 31, 2020 and December 31, 2019 Year To Date December 31 2020 2019 CASH FLOWS FROM OPERATING ACTIVITIES: Net income (loss) available to common stockholders $ 2,846,228 $ 4,554,192 Adjustments to reconcile net income (loss) Depreciation - - Common stock issued in settlement of debt - - (Increase) decrease in: Accounts receivable - - Inventories 0 - Prepaid expenses and other assets 0 - Accounts payable 92,753 111,318 Accrued liabilities (255,810) 553,356 Net cash (used in) operating activities 2,683,171 5,218,866 CASH FLOWS FROM INVESTING ACTIVITIES - - CASH FLOWS FROM FINANCING ACTIVITIES: Proceeds from the sale of common stock - - Net proceeds (payments) from borrowing on a long term basis (3,076,184) (5,218,866) Net proceeds (payments) from notes payable, related parties 392,982 - Net proceeds (payments) from warrants payable - - Net cash provided by financing activities (2,683,202) (5,218,866) Net increase in cash and cash equivalents (31) (0) Cash and cash equivalents at beginning of period 31 31 Cash and cash equivalents at end of period 0 31 Supplemental disclosures Interest Paid $ - $ - Income taxes paid $ - $ - NON-CASH INVESTING AND FINANCING ACTIVITIES:

Condensed Consolidated Balance Sheet Fiscal Year Ended December 31, 2020 and December 31, 2019 (Unaudited) December 31, 2020 December 31, 2019 Assets Current assets: Cash & cash equivalents $ - $ 31 Investment - restricted use - 63 Accounts Receivable, Allowance for Doubtful Accounts is $ 0 - - Inventory 78,838 78,838 Other current assets - - Total current assets 78,838 78,932 Property, plant and equipment, net of accumulated depreciation of $ 92,631 and $ 92,631 respectively - - Other Assets: Patents, net of accumulated amortization of $ 3,974,974 and $3,974,974 respectively - - Total Assets $ 78,838 $ 78,932 Liabilities and Deficiency in Stockholders' Equity Current liabilities: Accounts payable 1,081,962 989,209 Accrued interest 1,431,345 1,153,300 Accrued liabilities 2,208,404 2,742,322 Warrants payable - - Total current liabilities 4,721,711 4,884,831 Long-term liabilities: Notes payable, related parties 3,215,143 2,822,161 Notes payable, non-related parties 2,203,354 5,279,538 Total long-term liabilities 5,418,498 8,101,700 Deficiency Stockholders' equity: Preferred stock, $0.001 par value, 100,000,000 shares authorized Class A Preferred, 26.9806 and 26.9806 shares issued and outstanding as of December 31, 2020 and December 31, 2019 respectively 134,900 134,900

Class B Preferred, 100,000,000 and 100,000,000 shares issued and outstanding as of December 31, 2020 and December 31, 2019 respectively 100,000 100,000 Class C Preferred, 150,000 and 150,000 shares issued and 150 150 outstanding as of December 31, 2020 and December 31, 2019 respectively Common stock, $0.001 par value, 20,000,000,000 shares authorized, 4,481,275,578 and 4,481,275,578 shares issued and outstanding as of December 31, 2020 and December 31, 2019 respectively 4,481,276 4,481,276 Additional paid-in capital 17,537,502 17,537,502 Accumulated deficit (32,315,198) (35,161,426) Deficiency in stockholders' equity (10,196,271) (13,042,498) Total liabilities and (deficiency) in stockholders' equity $ 78,838 $ 78,932 The accompanying notes are an integral part of these financial statements.

Statement of Changes In Stockholders Equity For The Period Ended December 31, 2020 Class B Preferred Class C Preferred Additional Stock Stock Common Stock Paid-In Accumulated Shares Amount Shares Amount Shares Amount Capital Deficit Total Balance December 31, 2019 100,000,000 100,000 150,000 150 4,481,275,578 4,481,276 17,537,502 (35,161,426) (13,042,498) Net Income/ (Loss) (84,064) (84,064) Balance March 31, 2020 100,000,000 100,000 150,000 150 4,481,275,578 4,481,276 17,537,502 (35,245,490) (13,126,562) Net Income/ (Loss) (101,145) (101,145) Balance June 30, 2020 100,000,000 100,000 150,000 150 4,481,275,578 4,481,276 17,537,502 (35,346,635) (13,227,707) Net Income/ (Loss) (102,118) (102,118) Balance September 30, 2020 100,000,000 100,000 150,000 150 4,481,275,578 4,481,276 17,537,502 (35,448,753) (13,329,825) Net Income/ (Loss) 3,133,555 3,133,555 Balance December 31, 2020 100,000,000 100,000 150,000 150 4,481,275,578 4,481,276 17,537,502 (32,315,198) (10,196,270) NOTE A-SUMMARY OF ACCOUNTING POLICIES General A summary of the significant accounting policies applied in the preparation of the accompanying consolidated financial statements follows: Business and Basis of Presentation Cyberlux Corporation (the "Company") is incorporated on May 17, 2000 under the laws of the State of Nevada. The Company develops, manufactures and markets long -term portable lighting products for commercial and industrial users. While the Company has gener ated revenues from its sale of products, the Company has incurred expenses, and sustained losses. Consequently, its operations are subject to all risks inherent in the establishment of a new business enterprise. As of December 31, 2020, the Company has accumulated losses of $32,315,198. Going forward, we intend to fully leverage this net loss carry -forward and use this tax advantage to maximize our level of cash flow from operations as a competitive advantage. Revenue Recognition Revenues are recognized in the period that products are provided. For revenue from product sales, the Company recognizes

Components of inventories as of December 31, 2020 and December 31, 2019 are as follows: 2020 2019 Component parts $ 7,663 $ 7,663 Finished goods 71,175 71,175 0 0 Less: allowance for obsolete inventory 0 0 $ 78,838 $ 78,838 Property and Equipment Property and equipment are stated at cost. When retired or otherwise disposed, the related carrying value and accumulated depreciation are removed from the respective accounts and the net difference less any amount realized from disposition, is reflected in earnings. For financial statement purposes, property and equipment are recorded at cost and depreciated using the straight-line method over their estimated useful lives as follows: Furniture and fixtures 7 years Office equipment 3 to 5 years Leasehold improvements 5 years Manufacturing equipment 3 years Depreciation expense totaled $ -0- and $-0- for the years ended December 31, 2020 and 2019, respectively. Advertising costs The Company expenses all costs of marketing and advertising as incurred. Marketing and advertising costs totaled $-0- and $-0- for the years ended December 31, 2020 and 2019, respectively. Research and Development The Company accounts for research and development costs in accordance with the Financial Accounting Standards Board's Accounting Standards Codification 730 "Research and Development". Under ASC 730, all research and development costs must be charged to exp ense as incurred. Accordingly, internal research and development costs are expensed as incurred. Third-party research and developments costs are expensed when the contracted work has been performed or as milestone results have been achieved. Company-sponsored research and development costs related to both present and future products are expensed in the period incurred. The Company expenditures were $ -0- and $-0- on research and product development for the years ended December 31, 2020 and 2019, respectively. Reclassification Certain reclassifications have been made in prior year’s financial statements to conform to classifications used in the current year. Fair Values On January 1, 2008, the Company adopted Accounting Standards Codification 820, “Fair Value Measurements and Disclosures”. ASC 820 defines fair value, establishes a framework for measuring fair value, and enhances fair value measurement disclosure. The effective date for ASC 820 for all non- financial assets and non- financial liabilities, except those that are recognized or disclosed at fair value in the financial statements on a recurring basis (at least annually) was the

Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines Cyberlux Corporation 800 Park Offices Drive, Suite 3209 Research Triangle, NC 27709 984-363-6894 www.cyberlux.com info@cyberlux.com 3674 Annual Report For the Period Ending: December 31, 2020 (the “Reporting Period”) As of December 31, 2020, the number of shares outstanding of our Common Stock was: 4,481,275,578 As of September 30, 2020, the number of shares outstanding of our Common Stock was: 4,481,275,578 As of December 31, 2019, the number of shares outstanding of our Common Stock was: 4,481,275,578 Indicate by check mark whether the company is a shell company (as defined in Rule 405 of the Securities Act of 1933 and Rule 12b-2 of the Exchange Act of 1934): Yes: ☐ No: ☒ Indicate by check mark whether the company’s shell status has changed since the previous reporting period: Yes: ☐ No: ☒ Indicate by check mark whether a Change in Control1 of the company has occurred over this reporting period: Yes: ☐ No: ☒ 1) Name and address(es) of the issuer and its predecessors (if any) Cyberlux Corporation (the “Company”) was incorporated under the laws of the State of Nevada on May 17, 2000. Until December 31, 2004, the Company was a development stage enterprise as defined under Accounting Standards Codification 1 “Change in Control” shall mean any events resulting in: (i) Any “person” (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becoming the “beneficial owner” (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company’s then outstanding voting securities; (ii) The consummation of the sale or disposition by the Company of all or substantially all of the C ompany’s assets; (iii) A change in the composition of the Board occurring within a two (2) -year period, as a result of which fewer than a majority of the directors are directors immediately prior to such change; or (iv) The consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation.

Date of Note Issuance Outstanding Balance ($) Principal Amount at Issuance ($) Interest Accrued ($) Maturity Date Conversion Terms (e.g. pricing mechanism for determining conversion of instrument to shares) Name of Noteholder (entities must have individual with voting / investment control disclosed). Reason for Issuance (e.g. Loan, Services, etc.) Use the space below to provide any additional details, including footnotes to the table above: N/A 4) Financial Statements A. The following financial statements were prepared in accordance with: ☒ U.S. GAAP ☐ IFRS B. The financial statements for this reporting period were prepared by (name of individual) 4: Name: David D Downing Title: Chief Financial Officer Relationship to Issuer: Principal Financial and Accounting Officer We are providing the following financial statements as an integral part of this report. C. Balance Sheet; D. Statement of Income; E. Statement of Cash Flows; F. Statement of Retained Earnings (Statement of Changes in Stockholders’ Equity) G. Financial notes. 5) Issuer’s Business, Products and Services A. Summarize the issuer’s business operations (If the issuer does not have current operations, state “no operations”) Founded as an Advanced Lighting company in 2000, Cyberlux Corporation became a supplier to the Department of Defense (DoD) after being asked by the United States Air Force to leverage our unique Cyberlux LED lighting technologies to solve tough problems for elite Special Forces Teams; problems multiple aerospace and defense contractors had tried but failed to solve. In 2020, Cyberlux Management set out to re-engineer the Corporation using a proven approach to achieve both rapid revenue expansion and industry diversification simultaneously, leveraging a strategy for fueling acquisition, investment, and internal growth. The Company generates revenues from its sale of products and services through the performance of its business units, the Company has incurred expenses, and sustained losses. Consequently, its operations are subject to all risks inherent in the establishment of an ongoing business enterprise. As of December 31, 2020, the Company has accumulated losses of $32,315,198. Going forward, we intend to fully leverage this net loss carry -forward possible and use this tax advantage to maximize our cash flow from operations as a competitive advantage B. Please list any subsidiaries, parents, or affiliated companies. 4 The financial statements requested pursuant to this item must be prepared in accordance with US GAAP or IFRS by persons with sufficient financial skills.

As shown in the accompanying consolidated financial statements, the Company realized net income from operations of $125,632 for the year ended December 31, 2020. The Company's current liabilities exceeded its current assets by $4,642,873 as of December 31, 2020. Recent Accounting Pronouncements Effective July 1, 2009, the Company adopted the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 105 -10, Generally Accepted Accounting Principles – Overall (“ASC 105- 10”). ASC 105- 10 establishes the FASB Accounting Standards Codification (the “Codification”) as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in conformity with U.S. GAAP. Rules and interpretive releases of the SEC under authority of federal securities laws are also sources of authoritative U.S. GAAP for SEC registrants. All guidance contained in the Codification carries an equal level of authority. The Codification superseded al l existing non- SEC accounting and reporting standards. All other non- grandfathered, non-SEC accounting literature not included in the Codification is non-authoritative. The FASB will not issue new standards in the form of Statements, FASB Staff Positions o r Emerging Issues Task Force Abstracts. Instead, it will issue Accounting Standards Updates (“ASUs”). The FASB will not consider ASUs as authoritative in their own right. ASUs will serve only to update the Codification, provide background information about the guidance and provide the bases for conclusions on the change(s) in the Codification. References made to FASB guidance throughout this document have been updated for the Codification. Effective January 1, 2008, the Company adopted FASB ASC 820-10, Fair Value Measurements and Disclosures – Overall (“ASC 820-10”) with respect to its financial assets and liabilities. In February 2008, the FASB issued updated guidance related to fair value measurements, which is included in the Codification in ASC 820-10-55, Fair Value Measurements and Disclosures – Overall – Implementation Guidance and Illustrations. The updated guidance provided a one year deferral of the effective date of ASC 820- 10 for non-financial assets and non-financial liabilities, except those that are recognized or disclosed in the financial statements at fair value at least annually. Therefore, the Company adopted the provisions of ASC 820-10 for non- financial assets and non- financial liabilities effective January 1, 2009, and such adoption did not have a material impact on the Company’s consolidated results of operations or financial condition. Effective April 1, 2009, the Company adopted FASB ASC 820-10-65, Fair Value Measurements and Disclosures – Overall – Transition and Open Effective Date Information (“ASC 820-10-65”). ASC 820-10-65 provides additional guidance for estimating fair value in accordance with ASC 820- 10 when the volume and level of activity for an asset or liability have significantly decreased. ASC 820-10-65 also includes guidance on identifying circumstances that indicate a transaction is not orderly. The adoption of ASC 820- 10-65 did not have an impact on the Company’s consolidated results of operations or financial condition. Effective April 1, 2009, the Company adopted FAS B ASC 825-10-65, Financial Instruments – Overall – Transition and Open Effective Date Information (“ASC 825-10-65”). ASC 825-10-65 amends ASC 825-10 to require disclosures about fair value of financial instruments in interim financial statements as well as in annual financial statements and also amends ASC 270-10 to require those disclosures in all interim financial statements. The adoption of ASC 825 -10-65 did not have a material impact on the Company’s consolidated results of operations or financial condition. In May 2009, the FASB issued SFAS No. 165, “Subsequent Events”, which is included in ASC Topic 855, Subsequent Events. ASC Topic 855 established principles and requirements for evaluating and reporting subsequent events and distinguishes which subs equent events should be recognized in the financial statements versus which subsequent events should be disclosed in the financial statements. ASC Topic 855 also required disclosure of the date through which subsequent events are evaluated by management. A SC Topic 855 was effective for interim periods ending after June 15, 2009 and applies prospectively. Because ASC Topic 855 impacted the disclosure requirements, and not the accounting treatment for subsequent events, the adoption of ASC Topic 855 did not i mpact our results of operations or financial condition. See Note J for disclosures regarding our subsequent events.

Series A - Convertible Preferred stock The Company has also authorized 100,000,000 shares of Preferred Stock, with a par value of $.001 per share. On December 31, 2003, the Company filed a Certificate of Designation creating a Series A Convertible Preferred Stock classification for 200 shares. The Series A Preferred stated conversion price of $.10 per shares is subject to certain anti -dilution provisions in the event the Company issues shares of its common stock or common stock equivalents below the stated conversion price. Changes to the conversion price are charged to operations and included in unrealized gain (loss) relating to adjustment of derivative and warrant liability to fair value of underlying securities. In the year ended December 31, 2008, 1 of the Series A Preferred shareholders exercised the conversion right and exchanged 2 shares of Series A Preferred for 100,000 shares of the Company’s common stock The holders of the Series A Preferred shall have the right to vote, separately as a single class, at a meeting of the holders of the Series A P referred or by such holders' written consent or at any annual or special meeting of the stockholders of the Corporation on any of the following matters: (i) the creation, authorization, or issuance of any class or series of shares ranking on a parity with or senior to the Series A Preferred with respect to dividends or upon the liquidation, dissolution, or winding up of the Corporation, and (ii) any agreement or other corporate action which would adversely affect the powers, rights, or preferences of the holders of the Series A Preferred. The holders of record of the Series A Preferred shall be entitled to receive cumulative dividends at the rate of twelve percent per annum (12%) on the face value ($5,000 per share) when, if and as declared by the Board of Directors, if ever. All dividends, when paid, shall be payable in cash, or at the option of the Company, in shares of the Company’s common stock. Dividends on shares of the Series A Preferred that have not been redeemed shall be payable quarterly in arrear s, when, if and as declared by the Board of Directors, if ever, on a semi-annual basis. No dividend or distribution other than a dividend or distribution paid in Common Stock or in any other junior stock shall be declared or paid or set aside for payment on the Common Stock or on any other junior stock unless full cumulative dividends on all outstanding shares of the Series A Preferred shall have been declared and paid. These dividends are not recorded until declared by the Company. As of the year ended December 31, 2020, $0 in dividends was accumulated. Upon any liquidation, dissolution or winding up of the Corporation, whether voluntary or involuntary, and after payment of any senior liquidation preferences of any series of Preferred Stock and before any distribution or payment is made with respect to any Common Stock, holders of each share of the Series A Preferred shall be entitled to be paid an amount equal in the greater of (a) the face value denominated thereon subject to adjustment for stock splits, stock dividends, reorganizations, reclassification or other similar events (the "Adjusted Face Value") plus, in the case of each share, an amount equal to all dividends accrued or declared but unpaid thereon, computed to the date payment thereof is made available, or (b) such amount per share of the Series A Preferred immediately prior to such liquidation, dissolution or winding up, or (c) the liquidation preference of $5,000.00 per share, and the holders of the Series A Preferred shall not be entitled to any further payment, such amount payable with respect to the Series A Preferred being sometimes referred to as the "Liquidation Payments." Because the Series A Shares include a redemption feature that is outside of the control of the Company and the stated conversion price is subject to reset, the Company has classified the Series A Shares outside of stockholders' equity. The fair value at date of issuance was recorded outside of stockholders’ equity in the accompanying balance sheet. Dividends on the Series A Shares are reflected as a reduction of net income (loss) attributable to common stockholders. In connection with the issuance of the Series A Preferred and related warrants, the holders were granted certain registration rights in which the Company agr eed to timely file a registration statement to register the common shares and the shares underlying the warrants, obtain effectiveness of the registration statement by the SEC within ninety-five (95) days of December 31, 2003, and maintain the effectiveness of this registration statement for a preset time thereafter. In the event the Company fails to timely perform under the registration rights agreement, the Company agrees to pay the holders of the Series A Preferred liquidated damages in an amount equal to 1.5% of the aggregate amount invested by the holders for each 30-day period or pro rata for any portion thereof following the date by which the registration statement should have been effective. The initial

NOTE: (1) Cyberlux Management has now completed the effort to identify the Series A Preferred shareholders from the 2004 H.C. Wainwright capital raise, as referenced in the (7) above. These seven shareholders participated in a financing that took place in 2004 and never exercised their Series A Preferred conversion to Common Stock. As of December 31, 2020, there are 26.9806 shares of Series A Preferred stock outstanding, with each Series A share representing 250 shares of Common stock. Since December 31, 200 3, only 1 of the Series A Preferred shareholders (Mike Kelly on 06/04/2004, previously identified as the eighth Series A shareholder) has exercised the conversion rights and exchanged 1 share of Series A Preferred for 50,000 shares of the Company’s common stock. Subsequently in 2010, the Company restructured the Company’s common stock with a 200 to 1 reverse split. Going forward, the Series A Preferred conversion rights would exchange 1 share of Series A Preferred shares for 250 shares of the Company’s common stock. With full conversion of all the outstanding Series A Preferred stock of 26.9806 shares, the Company would issue a total of 6,745 shares of common stock. (2) Cyberlux Management is unaware of any 5% or more Common Stock shareholders. The report does not include any 5% or more Common Stock shareholders because Management is unaware of any such shareholders and believes there are no shareholders who own 25 0,000,000 or more Common Stock shares . 8) Legal/Disciplinary History A. Please identify whether any of the persons or entities listed above have, in the past 10 years, been the subject of: 1. A conviction in a criminal proceeding or named as a defendant in a pending criminal proceeding (excluding traffic violations and other minor offenses); None 2. The entry of an order, judgment, or decree, not subsequently reversed, suspended or vacated, by a court of competent jurisdiction that permanently or temporarily enjoined, barred, suspended or otherwise limited such person’s involvement in any type of business, securities, commodities, or banking activities; None 3. A finding or judgment by a court of competent jurisdiction (in a civil action), the Securities and Exchange Commission, the Commodity Futures Trading Commission, or a state securities regulator of a violation of federal or state securities or commodities law, which finding or judgment has not been reversed, suspended, or vacated; or None 4. The entry of an order by a self-regulatory organization that permanently or temporarily barred, suspended, or otherwise limited such person’s involvement in any type of business or securities activities. None B. Describe briefly any material pending legal proceedings, other than ordinary routine litigation incidental to the business, to which the issuer or any of its subsidiaries is a party or of which any of their property is the subject. Include the name of the court or agency in which the proceedings are pending, the date instituted, the principal parties divided by 200 for 2010 200 to 1 reverse split N/A N/A N/A N/A Options N/A No Options plans are in effect or outstanding N/A N/A N/A N/A Warrants N/A No Warrant plans are in effect or outstanding

The shares issued were valued at $25.20 per share, which repre sented the fair value of the common stock the shares are convertible into. None of the Series C Preferred shareholders have exercised their conversion right and there are 150,000 shares of Series C Preferred shares issued and outstanding at September 30, 2008. The holders of record of the Series C Preferred shall be entitled to receive cumulative dividends at the rate of five percent per annum (5%), compounded quarterly, on the face value ($25.00 per share) when, if and as declared by the Board of Directors, if ever. All dividends, when paid, shall be payable in cash, or at the option of the Company, in shares of the Company’s common stock. Dividends on shares of the Series C Preferred that have not been redeemed shall be payable quarterly in arrears, when, if and as declared by the Board of Directors, if ever, at the time of conversion. These dividends are not recorded until declared by the Company. As of December 31, 2020 $-0- in dividends were accumulated. Common stock The Company has authorized 20,000,000,000 shares of common stock, with a par value of $.001 per share. At July 28, 2010 the Board of Directors approved a motion to authorize a reverse split of the outstanding stock of 200:1. As of December 31, 2020 and Dec ember 31, 2019, the Company has 4,481,275,578 and 4,481,275,578 shares issued and outstanding, respectively. NOTE F - RELATED PARTY TRANSACTIONS From time to time, the Company's principal officers have advanced funds to the Company for working capital purposes in the form of unsecured promissory notes, accruing interest at 10% to 12% per annum. Loans from Officers Officer Principal Due Interest Rate Accrued Interest at 12/31/20 David Downing $ 799,610 10% $ 253,687 Mark Schmidt $ 762,421 10% $ 274,023 John Ringo $ 555,361 10% $ 196,951 $2,117,392 $ 724,661 All Others Principal Due Interest Rate Accrued Interest at 12/31/20 All Others $ 1,097,750 10% $ 374,063 $ 1,097,750 $ 374,063 NOTE G - COMMITMENTS AND CONTINGENCIES Consulting Agreements The Company has consulting agreements with outside contractors, certain of whom are also Company stockholders. The Agreements are generally for a term of 12 months from inception and renewable automatically from year to year unless either the Company or Consultant terminates such engagement by written notice. Litigation The Company is subject to other legal proceedings and claims, which arise in the ordinary course of its business. Although occasional adverse decisions or settlements may occur, the Compa ny believes that the final disposition of such matters

NOTE: (1) Cyberlux Management has now completed the effort to identify the Series A Preferred shareholders from the 2004 H.C. Wainwright capital raise, as referenced in the (7) above. These seven shareholders participated in a financing that took place in 2004 and never exercised their Series A Preferred conversion to Common Stock. As of December 31, 2020, there are 26.9806 shares of Series A Preferred stock outstanding, with each Series A share representing 250 shares of Common stock. Since December 31, 200 3, only 1 of the Series A Preferred shareholders (Mike Kelly on 06/04/2004, previously identified as the eighth Series A shareholder) has exercised the conversion rights and exchanged 1 share of Series A Preferred for 50,000 shares of the Company’s common stock. Subsequently in 2010, the Company restructured the Company’s common stock with a 200 to 1 reverse split. Going forward, the Series A Preferred conversion rights would exchange 1 share of Series A Preferred shares for 250 shares of the Company’s common stock. With full conversion of all the outstanding Series A Preferred stock of 26.9806 shares, the Company would issue a total of 6,745 shares of common stock. (2) Cyberlux Management is unaware of any 5% or more Common Stock shareholders. The report does not include any 5% or more Common Stock shareholders because Management is unaware of any such shareholders and believes there are no shareholders who own 25 0,000,000 or more Common Stock shares . 8) Legal/Disciplinary History A. Please identify whether any of the persons or entities listed above have, in the past 10 years, been the subject of: 1. A conviction in a criminal proceeding or named as a defendant in a pending criminal proceeding (excluding traffic violations and other minor offenses); None 2. The entry of an order, judgment, or decree, not subsequently reversed, suspended or vacated, by a court of competent jurisdiction that permanently or temporarily enjoined, barred, suspended or otherwise limited such person’s involvement in any type of business, securities, commodities, or banking activities; None 3. A finding or judgment by a court of competent jurisdiction (in a civil action), the Securities and Exchange Commission, the Commodity Futures Trading Commission, or a state securities regulator of a violation of federal or state securities or commodities law, which finding or judgment has not been reversed, suspended, or vacated; or None 4. The entry of an order by a self-regulatory organization that permanently or temporarily barred, suspended, or otherwise limited such person’s involvement in any type of business or securities activities. None B. Describe briefly any material pending legal proceedings, other than ordinary routine litigation incidental to the business, to which the issuer or any of its subsidiaries is a party or of which any of their property is the subject. Include the name of the court or agency in which the proceedings are pending, the date instituted, the principal parties divided by 200 for 2010 200 to 1 reverse split N/A N/A N/A N/A Options N/A No Options plans are in effect or outstanding N/A N/A N/A N/A Warrants N/A No Warrant plans are in effect or outstanding

The shares issued were valued at $25.20 per share, which repre sented the fair value of the common stock the shares are convertible into. None of the Series C Preferred shareholders have exercised their conversion right and there are 150,000 shares of Series C Preferred shares issued and outstanding at September 30, 2008. The holders of record of the Series C Preferred shall be entitled to receive cumulative dividends at the rate of five percent per annum (5%), compounded quarterly, on the face value ($25.00 per share) when, if and as declared by the Board of Directors, if ever. All dividends, when paid, shall be payable in cash, or at the option of the Company, in shares of the Company’s common stock. Dividends on shares of the Series C Preferred that have not been redeemed shall be payable quarterly in arrears, when, if and as declared by the Board of Directors, if ever, at the time of conversion. These dividends are not recorded until declared by the Company. As of December 31, 2020 $-0- in dividends were accumulated. Common stock The Company has authorized 20,000,000,000 shares of common stock, with a par value of $.001 per share. At July 28, 2010 the Board of Directors approved a motion to authorize a reverse split of the outstanding stock of 200:1. As of December 31, 2020 and Dec ember 31, 2019, the Company has 4,481,275,578 and 4,481,275,578 shares issued and outstanding, respectively. NOTE F - RELATED PARTY TRANSACTIONS From time to time, the Company's principal officers have advanced funds to the Company for working capital purposes in the form of unsecured promissory notes, accruing interest at 10% to 12% per annum. Loans from Officers Officer Principal Due Interest Rate Accrued Interest at 12/31/20 David Downing $ 799,610 10% $ 253,687 Mark Schmidt $ 762,421 10% $ 274,023 John Ringo $ 555,361 10% $ 196,951 $2,117,392 $ 724,661 All Others Principal Due Interest Rate Accrued Interest at 12/31/20 All Others $ 1,097,750 10% $ 374,063 $ 1,097,750 $ 374,063 NOTE G - COMMITMENTS AND CONTINGENCIES Consulting Agreements The Company has consulting agreements with outside contractors, certain of whom are also Company stockholders. The Agreements are generally for a term of 12 months from inception and renewable automatically from year to year unless either the Company or Consultant terminates such engagement by written notice. Litigation The Company is subject to other legal proceedings and claims, which arise in the ordinary course of its business. Although occasional adverse decisions or settlements may occur, the Compa ny believes that the final disposition of such matters

should not have a material adverse effect on its consolidated financial position, results of operations or liquidity. There was no outstanding litigation as of December 31, 2020. NOTE H - FAIR VALUES Accounting Standards Codification 820 "Fair Value Measurements and Disclosures" defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. ASC 820 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes three levels of inputs that may be used to measure fair value: Level 1 - Quoted prices in active markets for identical assets or liabilities. Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant in puts are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 - Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to meas ure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed is determined based on the lowest level input that is significant to the fair value measurement. Items recorded or measured at fair value on a recurring basis in the accompanying financial statements consisted of the following items as of December 31, 2020: Total Quoted Prices in Active Markets for Identical Instrument s Level 1 Significant Other Observable Inputs Level 2 Significant Unobservable Inputs Level 3 Liabilities: Derivative liability 0 0 ) Warrant payable (0) (0) ) Warrant liability (0) 0 ) Total $ (0) $ (0) With the exception of assets and liabilities included within the scope of Accounting Standards Codification 820 "Fair Value Measurements and Disclosures", the Company adopted the provisions of ASC 820 prospectively effective as of the beginning of Fiscal 2008. For financial assets and liabilities included within the scope of ASC 820, the Company will be required to adopt the provisions of ASC 820 prospectively as of the beginning of Fiscal 2009. The adoption of ASC 820 did not have a material impact on our financial position or results of operations and the Company do not believe that the adoption of ASC 820 will have a material impact on our financial position or results of operations.

NOTE I - GOING CONCERN MATTERS The accompanying statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the accompanying consolidated financial statements, as of December 31, 2020, the Company incurred accumulated losses of $ 32,315,198. The Company’s current liabilities exceeded its current assets by $4,642,873 as of December 31, 2020. While this factors among others may indicate that the Company will be unable t o continue as a going concern, Management is confident that business performance in 2022 will ensure the Company is an ongoing growth business for the foreseeable future. The Company is actively pursuing additional business growth across four distinct bus iness units through acquisitions, organic growth and new customers and product that will increase the associated cash flow from operations. However, no assurance can be given that Management's actions will result in profitable operations or the of its liquidity problems. NOTE J - SUBSEQUENT EVENTS Management has determined that no significant subsequent events occurred since the balance sheet date. NOTE K - CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE None. NOTE L - CONTROLS AND PROCEDURES Evaluation of Disclosure Controls and Procedures The Company’s management, under the supervision of the Company’s Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the eff ectiveness of the design and operation of our disclosure controls and procedures. Disclosure controls and procedures mean our controls and other procedures that are designed to ensure that information required to be disclosed in the reports that we file or submit is recorded, processed, summarized and reported within the time periods required. Disclosure controls and procedures are also designed to provide reasonable assurance that such information is accumulated and communicated to our management, including the chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure. Our quarterly evaluation of disclosure controls and procedures includes an evaluation of some components of our internal control over financial reporting, and internal control over financial reporting is also separately evaluated on an annual basis for purposes of providing the management report that is set forth below. At the same time our disclosure controls and procedures can identify weaknesses in our financial reporting and control systems that require remediated action. The evaluation conducted included the design, as well as the implementation, of the disclosure controls and procedures, and how the output produced was us ed in the preparation of this Annual Report. In the course of performing this evaluation, particular attention was paid to identifying past, present and potential occurrences of data errors, problems of control, and the potential for fraud. Our Chief Executive Officer and Chief Financial Officer have concluded, based on the evaluation of the effectiveness of the disclosure controls and procedures by our management, that as of December 31, 2020 our disclosure controls and procedures were effective. Management’s Report on Internal Control over Financial Reporting Our management is responsible for the establishment and maintenance of an adequate system of internal controls over financial reporting. Internal control over financial reporting is a process design ed by, or under the supervision of, our

NOTE I - GOING CONCERN MATTERS The accompanying statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the accompanying consolidated financial statements, as of December 31, 2020, the Company incurred accumulated losses of $ 32,315,198. The Company’s current liabilities exceeded its current assets by $4,642,873 as of December 31, 2020. While this factors among others may indicate that the Company will be unable t o continue as a going concern, Management is confident that business performance in 2022 will ensure the Company is an ongoing growth business for the foreseeable future. The Company is actively pursuing additional business growth across four distinct bus iness units through acquisitions, organic growth and new customers and product that will increase the associated cash flow from operations. However, no assurance can be given that Management's actions will result in profitable operations or the of its liquidity problems. NOTE J - SUBSEQUENT EVENTS Management has determined that no significant subsequent events occurred since the balance sheet date. NOTE K - CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE None. NOTE L - CONTROLS AND PROCEDURES Evaluation of Disclosure Controls and Procedures The Company’s management, under the supervision of the Company’s Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the eff ectiveness of the design and operation of our disclosure controls and procedures. Disclosure controls and procedures mean our controls and other procedures that are designed to ensure that information required to be disclosed in the reports that we file or submit is recorded, processed, summarized and reported within the time periods required. Disclosure controls and procedures are also designed to provide reasonable assurance that such information is accumulated and communicated to our management, including the chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure. Our quarterly evaluation of disclosure controls and procedures includes an evaluation of some components of our internal control over financial reporting, and internal control over financial reporting is also separately evaluated on an annual basis for purposes of providing the management report that is set forth below. At the same time our disclosure controls and procedures can identify weaknesses in our financial reporting and control systems that require remediated action. The evaluation conducted included the design, as well as the implementation, of the disclosure controls and procedures, and how the output produced was us ed in the preparation of this Annual Report. In the course of performing this evaluation, particular attention was paid to identifying past, present and potential occurrences of data errors, problems of control, and the potential for fraud. Our Chief Executive Officer and Chief Financial Officer have concluded, based on the evaluation of the effectiveness of the disclosure controls and procedures by our management, that as of December 31, 2020 our disclosure controls and procedures were effective. Management’s Report on Internal Control over Financial Reporting Our management is responsible for the establishment and maintenance of an adequate system of internal controls over financial reporting. Internal control over financial reporting is a process design ed by, or under the supervision of, our

Par or stated value: $0.001 Total shares authorized: 200 as of date: December 31, 2020 Total shares outstanding: 26.9806 as of date: December 31, 2020 Total number of shareholders of record: 7 as of date: December 31, 2020 Trading symbol: CYBL Exact title and class of securities outstanding: Preferred Stock – Class B CUSIP: NA Par or stated value: $0.001 Total shares authorized: 100,000,000 as of date: December 31, 2020 Total shares outstanding: 100,000,000 as of date: December 31, 2020 Total number of shareholders of record: 3 as of date: December 31, 2020 Trading symbol: CYBL Exact title and class of securities outstanding: Preferred Stock – Class C CUSIP: NA Par or stated value: $0.001 Total shares authorized: 150,000 as of date: December 31, 2020 Total shares outstanding: 150,000 as of date: December 31, 2020 Total number of shareholders of record: 2 as of date: December 31, 2020 Transfer Agent Name: Standard Registrar and Transfer Company, Inc. Phone: 801-571-8844 Email: amy@standardregistrar.com Address: 440 E 400 S Suite 200, Salt Lake City, UT 84111 Is the Transfer Agent registered under the Exchange Act? 3 Yes: ☒ No: ☐ 3) Issuance History The goal of this section is to provide disclosure with respect to each event that resulted in any direct changes to the total shares outstanding of any class of the issuer’s securities in the past two completed fiscal years and any subsequent interim period. Disclosure under this item shall include, in chronological order, all offerings and issuances of securities, including debt convertible into equity securities, whether private or public, and all shares, or any other securities or options to acquire such securities, issued for services. Using the tabular format below, please describe these events. A. Changes to the Number of Outstanding Shares Check this box to indicate there were no changes to the number of outstanding shares within the past two completed fiscal years and any subsequent periods: ☒ 3 To be included in the Pink Current Information tier, the transfer agent must be registered under the Exchange Act. Shares Outstanding as of Second Most Recent Fiscal Year End: Opening Balance Date 12/31/2018 Common: 4,481,275,578 Preferred: A: 26.9806 B: 100,000,000 C: 150,000 *Right-click the rows below and select “Insert” to add rows as needed.

NOTE I - GOING CONCERN MATTERS The accompanying statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the accompanying consolidated financial statements, as of December 31, 2020, the Company incurred accumulated losses of $ 32,315,198. The Company’s current liabilities exceeded its current assets by $4,642,873 as of December 31, 2020. While this factors among others may indicate that the Company will be unable t o continue as a going concern, Management is confident that business performance in 2022 will ensure the Company is an ongoing growth business for the foreseeable future. The Company is actively pursuing additional business growth across four distinct bus iness units through acquisitions, organic growth and new customers and product that will increase the associated cash flow from operations. However, no assurance can be given that Management's actions will result in profitable operations or the of its liquidity problems. NOTE J - SUBSEQUENT EVENTS Management has determined that no significant subsequent events occurred since the balance sheet date. NOTE K - CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE None. NOTE L - CONTROLS AND PROCEDURES Evaluation of Disclosure Controls and Procedures The Company’s management, under the supervision of the Company’s Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the eff ectiveness of the design and operation of our disclosure controls and procedures. Disclosure controls and procedures mean our controls and other procedures that are designed to ensure that information required to be disclosed in the reports that we file or submit is recorded, processed, summarized and reported within the time periods required. Disclosure controls and procedures are also designed to provide reasonable assurance that such information is accumulated and communicated to our management, including the chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure. Our quarterly evaluation of disclosure controls and procedures includes an evaluation of some components of our internal control over financial reporting, and internal control over financial reporting is also separately evaluated on an annual basis for purposes of providing the management report that is set forth below. At the same time our disclosure controls and procedures can identify weaknesses in our financial reporting and control systems that require remediated action. The evaluation conducted included the design, as well as the implementation, of the disclosure controls and procedures, and how the output produced was us ed in the preparation of this Annual Report. In the course of performing this evaluation, particular attention was paid to identifying past, present and potential occurrences of data errors, problems of control, and the potential for fraud. Our Chief Executive Officer and Chief Financial Officer have concluded, based on the evaluation of the effectiveness of the disclosure controls and procedures by our management, that as of December 31, 2020 our disclosure controls and procedures were effective. Management’s Report on Internal Control over Financial Reporting Our management is responsible for the establishment and maintenance of an adequate system of internal controls over financial reporting. Internal control over financial reporting is a process design ed by, or under the supervision of, our

Item 14. Beneficial Owners. The following entities own five percent (5%) or more of the shares of the Company's Common Stock: None. Item 15. The name, address, telephone number, and email address of each of the following outside providers that advise the issuer on matters relating to the operations, business development and disclosure: 1. Investment Banker The Company is actively pursuing an investment banking relationship but has not engaged an investment banker at this time. 2. Promoters The Company has not engaged a promoter. 3. Counsel John W Ringo Attorney at Law 241 Lamplighter Lane Marietta, GA 30067 4. Public Relations Consultant(s) N/A 5. Investor Relations Consultant N/A 6. Any other advisor(s) that assisted, advised, prepared or provided information with respect to this disclosure statement. None. Item 16. Management's Discussion and Analysis or Plan of Operation. A. Plan of Operation. Please refer to Item 9A. B. Management's Discussion and Analysis of Financial Condition and Results of Operations. Year ended December 31, 2020 compared to the Year ended December 31, 2019 REVENUES Revenues for the year ended December 31, 2020 were $-0- as compared to $-0- for the same period last year. The lack of revenue was attributed t o the impact of the C OVID pandemic during 2020, which resulted in an almost

Each Share of Series A = 250 Shares of Common John G. Hule None West Berlin, NJ 2.5806 Series A 10% 2004 H.C. Wainwright Capital Raise Each Share of Series A = 250 Shares of Common Charles O’Brien None Boston, MA 1.4000 Series A 5% 2004 H.C. Wainwright Capital Raise Each Share of Series A = 250 Shares of Common Ward L. Snyder None Tucson, AZ 3.0000 Series A 11% 2004 H.C. Wainwright Capital Raise Each Share of Series A = 250 Shares of Common Mark D Schmidt Officer Durham, NC 44,000,000 Series B 44% Poison-Pill Voting Control Protection John W Ringo Officer Atlanta, GA 25,000,000 Series B 25% Poison-Pill Voting Control Protection David D Downing Officer Marietta, OH 31,000,000 Series B 31% Poison-Pill Voting Control Protection University of California - Santa Barbara Kevin Stewart Director of UCSB Office of Technology & Industry Alliances Santa Barbara, CA 75,000 Series C 50% 2006 Technology Transfer Agreement Each Share of Series C = $25.20 divided by the 10 day moving average closing price, then divided by 200 for 2010 200 to 1 reverse split Rensselaer Polytechnic Institute Tasha Sanford Office of Intellectual Property Optimization Troy, NY 75,000 Series C 50% 2006 Technology Transfer Agreement Each Share of Series C = $25.20 divided by the 10 day moving average closing price, then

NA C. Describe the issuers’ principal products or services. The Company has a range of Advanced Lighting Solutions (ALS), including Cyberlux Advanced Infrared and White LED Lighting System Platform. The products are used as Solutions across U.S. agencies, and has ongoing Strategic IP development with legacy and future Strategic Partner technologies. Cyberlux intends to introduce products and solutions across multiple industries in 2021, going well beyond the hardened multispectral illuminators Cyberlux had become known for. 6) Issuer’s Facilities We maintain our principal office at 800 Park Offices Drive, Suite 3209, Research Triangle Park, NC 27709. We have our South American headquarters in Bogota, Colombia is located at Carrara 7 #74B 56 Edificio Corficaldas Office 703. 7) Company Insiders (Officers, Directors, and Control Persons) Name of Officer/Director or Control Person Affiliation with Company (e.g. Officer Title /Director/Owner of more than 5%) Residential Address (City / State Only) Number of shares owned Share type/class Ownership Percentage of Class Outstanding Note Lon E. Bell None Altadena, CA 10.0000 Series A 37% 2004 H.C. Wainwright Capital Raise Each Share of Series A = 250 Shares of Common Christina Crossman None Westmoreland, NY 4.0000 Series A 15% 2004 H.C. Wainwright Capital Raise Each Share of Series A = 250 Shares of Common David W. Eckert None Rocky Mount, NC 1.0000 Series A 4% 2004 H.C. Wainwright Capital Raise Each Share of Series A = 250 Shares of Common Neal M. Goldstein None Los Angeles, CA 5.0000 Series A 19% 2004 H.C. Wainwright Capital Raise

NOTE: (1) Cyberlux Management has now completed the effort to identify the Series A Preferred shareholders from the 2004 H.C. Wainwright capital raise, as referenced in the (7) above. These seven shareholders participated in a financing that took place in 2004 and never exercised their Series A Preferred conversion to Common Stock. As of December 31, 2020, there are 26.9806 shares of Series A Preferred stock outstanding, with each Series A share representing 250 shares of Common stock. Since December 31, 200 3, only 1 of the Series A Preferred shareholders (Mike Kelly on 06/04/2004, previously identified as the eighth Series A shareholder) has exercised the conversion rights and exchanged 1 share of Series A Preferred for 50,000 shares of the Company’s common stock. Subsequently in 2010, the Company restructured the Company’s common stock with a 200 to 1 reverse split. Going forward, the Series A Preferred conversion rights would exchange 1 share of Series A Preferred shares for 250 shares of the Company’s common stock. With full conversion of all the outstanding Series A Preferred stock of 26.9806 shares, the Company would issue a total of 6,745 shares of common stock. (2) Cyberlux Management is unaware of any 5% or more Common Stock shareholders. The report does not include any 5% or more Common Stock shareholders because Management is unaware of any such shareholders and believes there are no shareholders who own 25 0,000,000 or more Common Stock shares . 8) Legal/Disciplinary History A. Please identify whether any of the persons or entities listed above have, in the past 10 years, been the subject of: 1. A conviction in a criminal proceeding or named as a defendant in a pending criminal proceeding (excluding traffic violations and other minor offenses); None 2. The entry of an order, judgment, or decree, not subsequently reversed, suspended or vacated, by a court of competent jurisdiction that permanently or temporarily enjoined, barred, suspended or otherwise limited such person’s involvement in any type of business, securities, commodities, or banking activities; None 3. A finding or judgment by a court of competent jurisdiction (in a civil action), the Securities and Exchange Commission, the Commodity Futures Trading Commission, or a state securities regulator of a violation of federal or state securities or commodities law, which finding or judgment has not been reversed, suspended, or vacated; or None 4. The entry of an order by a self-regulatory organization that permanently or temporarily barred, suspended, or otherwise limited such person’s involvement in any type of business or securities activities. None B. Describe briefly any material pending legal proceedings, other than ordinary routine litigation incidental to the business, to which the issuer or any of its subsidiaries is a party or of which any of their property is the subject. Include the name of the court or agency in which the proceedings are pending, the date instituted, the principal parties divided by 200 for 2010 200 to 1 reverse split N/A N/A N/A N/A Options N/A No Options plans are in effect or outstanding N/A N/A N/A N/A Warrants N/A No Warrant plans are in effect or outstanding

Date of Note Issuance Outstanding Balance ($) Principal Amount at Issuance ($) Interest Accrued ($) Maturity Date Conversion Terms (e.g. pricing mechanism for determining conversion of instrument to shares) Name of Noteholder (entities must have individual with voting / investment control disclosed). Reason for Issuance (e.g. Loan, Services, etc.) Use the space below to provide any additional details, including footnotes to the table above: N/A 4) Financial Statements A. The following financial statements were prepared in accordance with: ☒ U.S. GAAP ☐ IFRS B. The financial statements for this reporting period were prepared by (name of individual) 4: Name: David D Downing Title: Chief Financial Officer Relationship to Issuer: Principal Financial and Accounting Officer We are providing the following financial statements as an integral part of this report. C. Balance Sheet; D. Statement of Income; E. Statement of Cash Flows; F. Statement of Retained Earnings (Statement of Changes in Stockholders’ Equity) G. Financial notes. 5) Issuer’s Business, Products and Services A. Summarize the issuer’s business operations (If the issuer does not have current operations, state “no operations”) Founded as an Advanced Lighting company in 2000, Cyberlux Corporation became a supplier to the Department of Defense (DoD) after being asked by the United States Air Force to leverage our unique Cyberlux LED lighting technologies to solve tough problems for elite Special Forces Teams; problems multiple aerospace and defense contractors had tried but failed to solve. In 2020, Cyberlux Management set out to re-engineer the Corporation using a proven approach to achieve both rapid revenue expansion and industry diversification simultaneously, leveraging a strategy for fueling acquisition, investment, and internal growth. The Company generates revenues from its sale of products and services through the performance of its business units, the Company has incurred expenses, and sustained losses. Consequently, its operations are subject to all risks inherent in the establishment of an ongoing business enterprise. As of December 31, 2020, the Company has accumulated losses of $32,315,198. Going forward, we intend to fully leverage this net loss carry -forward possible and use this tax advantage to maximize our cash flow from operations as a competitive advantage B. Please list any subsidiaries, parents, or affiliated companies. 4 The financial statements requested pursuant to this item must be prepared in accordance with US GAAP or IFRS by persons with sufficient financial skills.

Date of Note Issuance Outstanding Balance ($) Principal Amount at Issuance ($) Interest Accrued ($) Maturity Date Conversion Terms (e.g. pricing mechanism for determining conversion of instrument to shares) Name of Noteholder (entities must have individual with voting / investment control disclosed). Reason for Issuance (e.g. Loan, Services, etc.) Use the space below to provide any additional details, including footnotes to the table above: N/A 4) Financial Statements A. The following financial statements were prepared in accordance with: ☒ U.S. GAAP ☐ IFRS B. The financial statements for this reporting period were prepared by (name of individual) 4: Name: David D Downing Title: Chief Financial Officer Relationship to Issuer: Principal Financial and Accounting Officer We are providing the following financial statements as an integral part of this report. C. Balance Sheet; D. Statement of Income; E. Statement of Cash Flows; F. Statement of Retained Earnings (Statement of Changes in Stockholders’ Equity) G. Financial notes. 5) Issuer’s Business, Products and Services A. Summarize the issuer’s business operations (If the issuer does not have current operations, state “no operations”) Founded as an Advanced Lighting company in 2000, Cyberlux Corporation became a supplier to the Department of Defense (DoD) after being asked by the United States Air Force to leverage our unique Cyberlux LED lighting technologies to solve tough problems for elite Special Forces Teams; problems multiple aerospace and defense contractors had tried but failed to solve. In 2020, Cyberlux Management set out to re-engineer the Corporation using a proven approach to achieve both rapid revenue expansion and industry diversification simultaneously, leveraging a strategy for fueling acquisition, investment, and internal growth. The Company generates revenues from its sale of products and services through the performance of its business units, the Company has incurred expenses, and sustained losses. Consequently, its operations are subject to all risks inherent in the establishment of an ongoing business enterprise. As of December 31, 2020, the Company has accumulated losses of $32,315,198. Going forward, we intend to fully leverage this net loss carry -forward possible and use this tax advantage to maximize our cash flow from operations as a competitive advantage B. Please list any subsidiaries, parents, or affiliated companies. 4 The financial statements requested pursuant to this item must be prepared in accordance with US GAAP or IFRS by persons with sufficient financial skills.

10) Issuer Certification Principal Executive Officer: The issuer shall include certifications by the chief executive officer and chief financial officer of the issuer (or any other persons with different titles but having the same responsibilities) in each Annual Report or Annual Report. The certifications shall follow the format below: I, Mark D Schmidt certify that: 1. I have reviewed this Annual disclosure statement of Cyberlux Corporation; 2. Based on my knowledge, this disclosure statement does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this disclosure statement; and 3. Based on my knowledge, the financial statements, and other financial information included or incorporated by reference in this disclosure statement, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this disclosure statement. December 6, 2022 /s/ Mark D Schmidt Principal Financial Officer: I, David D Downing certify that: 1. I have reviewed this Annual disclosure statement of Cyberlux Corporation; 2. Based on my knowledge, this disclosure statement does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this disclosure statement; and 3. Based on my knowledge, the financial statements, and other financial information included or incorporated by reference in this disclosure statement, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this disclosure statement. December 6, 2020 /s/ David D Downing

Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines Cyberlux Corporation 800 Park Offices Drive, Suite 3209 Research Triangle, NC 27709 984-363-6894 www.cyberlux.com info@cyberlux.com 3674 Annual Report For the Period Ending: December 31, 2020 (the “Reporting Period”) As of December 31, 2020, the number of shares outstanding of our Common Stock was: 4,481,275,578 As of September 30, 2020, the number of shares outstanding of our Common Stock was: 4,481,275,578 As of December 31, 2019, the number of shares outstanding of our Common Stock was: 4,481,275,578 Indicate by check mark whether the company is a shell company (as defined in Rule 405 of the Securities Act of 1933 and Rule 12b-2 of the Exchange Act of 1934): Yes: ☐ No: ☒ Indicate by check mark whether the company’s shell status has changed since the previous reporting period: Yes: ☐ No: ☒ Indicate by check mark whether a Change in Control1 of the company has occurred over this reporting period: Yes: ☐ No: ☒ 1) Name and address(es) of the issuer and its predecessors (if any) Cyberlux Corporation (the “Company”) was incorporated under the laws of the State of Nevada on May 17, 2000. Until December 31, 2004, the Company was a development stage enterprise as defined under Accounting Standards Codification 1 “Change in Control” shall mean any events resulting in: (i) Any “person” (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becoming the “beneficial owner” (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company’s then outstanding voting securities; (ii) The consummation of the sale or disposition by the Company of all or substantially all of the C ompany’s assets; (iii) A change in the composition of the Board occurring within a two (2) -year period, as a result of which fewer than a majority of the directors are directors immediately prior to such change; or (iv) The consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation.

10) Issuer Certification Principal Executive Officer: The issuer shall include certifications by the chief executive officer and chief financial officer of the issuer (or any other persons with different titles but having the same responsibilities) in each Annual Report or Annual Report. The certifications shall follow the format below: I, Mark D Schmidt certify that: 1. I have reviewed this Annual disclosure statement of Cyberlux Corporation; 2. Based on my knowledge, this disclosure statement does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this disclosure statement; and 3. Based on my knowledge, the financial statements, and other financial information included or incorporated by reference in this disclosure statement, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this disclosure statement. December 6, 2022 /s/ Mark D Schmidt Principal Financial Officer: I, David D Downing certify that: 1. I have reviewed this Annual disclosure statement of Cyberlux Corporation; 2. Based on my knowledge, this disclosure statement does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this disclosure statement; and 3. Based on my knowledge, the financial statements, and other financial information included or incorporated by reference in this disclosure statement, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this disclosure statement. December 6, 2020 /s/ David D Downing

10) Issuer Certification Principal Executive Officer: The issuer shall include certifications by the chief executive officer and chief financial officer of the issuer (or any other persons with different titles but having the same responsibilities) in each Annual Report or Annual Report. The certifications shall follow the format below: I, Mark D Schmidt certify that: 1. I have reviewed this Annual disclosure statement of Cyberlux Corporation; 2. Based on my knowledge, this disclosure statement does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this disclosure statement; and 3. Based on my knowledge, the financial statements, and other financial information included or incorporated by reference in this disclosure statement, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this disclosure statement. December 6, 2022 /s/ Mark D Schmidt Principal Financial Officer: I, David D Downing certify that: 1. I have reviewed this Annual disclosure statement of Cyberlux Corporation; 2. Based on my knowledge, this disclosure statement does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this disclosure statement; and 3. Based on my knowledge, the financial statements, and other financial information included or incorporated by reference in this disclosure statement, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this disclosure statement. December 6, 2020 /s/ David D Downing

Each Share of Series A = 250 Shares of Common John G. Hule None West Berlin, NJ 2.5806 Series A 10% 2004 H.C. Wainwright Capital Raise Each Share of Series A = 250 Shares of Common Charles O’Brien None Boston, MA 1.4000 Series A 5% 2004 H.C. Wainwright Capital Raise Each Share of Series A = 250 Shares of Common Ward L. Snyder None Tucson, AZ 3.0000 Series A 11% 2004 H.C. Wainwright Capital Raise Each Share of Series A = 250 Shares of Common Mark D Schmidt Officer Durham, NC 44,000,000 Series B 44% Poison-Pill Voting Control Protection John W Ringo Officer Atlanta, GA 25,000,000 Series B 25% Poison-Pill Voting Control Protection David D Downing Officer Marietta, OH 31,000,000 Series B 31% Poison-Pill Voting Control Protection University of California - Santa Barbara Kevin Stewart Director of UCSB Office of Technology & Industry Alliances Santa Barbara, CA 75,000 Series C 50% 2006 Technology Transfer Agreement Each Share of Series C = $25.20 divided by the 10 day moving average closing price, then divided by 200 for 2010 200 to 1 reverse split Rensselaer Polytechnic Institute Tasha Sanford Office of Intellectual Property Optimization Troy, NY 75,000 Series C 50% 2006 Technology Transfer Agreement Each Share of Series C = $25.20 divided by the 10 day moving average closing price, then

Par or stated value: $0.001 Total shares authorized: 200 as of date: December 31, 2020 Total shares outstanding: 26.9806 as of date: December 31, 2020 Total number of shareholders of record: 7 as of date: December 31, 2020 Trading symbol: CYBL Exact title and class of securities outstanding: Preferred Stock – Class B CUSIP: NA Par or stated value: $0.001 Total shares authorized: 100,000,000 as of date: December 31, 2020 Total shares outstanding: 100,000,000 as of date: December 31, 2020 Total number of shareholders of record: 3 as of date: December 31, 2020 Trading symbol: CYBL Exact title and class of securities outstanding: Preferred Stock – Class C CUSIP: NA Par or stated value: $0.001 Total shares authorized: 150,000 as of date: December 31, 2020 Total shares outstanding: 150,000 as of date: December 31, 2020 Total number of shareholders of record: 2 as of date: December 31, 2020 Transfer Agent Name: Standard Registrar and Transfer Company, Inc. Phone: 801-571-8844 Email: amy@standardregistrar.com Address: 440 E 400 S Suite 200, Salt Lake City, UT 84111 Is the Transfer Agent registered under the Exchange Act? 3 Yes: ☒ No: ☐ 3) Issuance History The goal of this section is to provide disclosure with respect to each event that resulted in any direct changes to the total shares outstanding of any class of the issuer’s securities in the past two completed fiscal years and any subsequent interim period. Disclosure under this item shall include, in chronological order, all offerings and issuances of securities, including debt convertible into equity securities, whether private or public, and all shares, or any other securities or options to acquire such securities, issued for services. Using the tabular format below, please describe these events. A. Changes to the Number of Outstanding Shares Check this box to indicate there were no changes to the number of outstanding shares within the past two completed fiscal years and any subsequent periods: ☒ 3 To be included in the Pink Current Information tier, the transfer agent must be registered under the Exchange Act. Shares Outstanding as of Second Most Recent Fiscal Year End: Opening Balance Date 12/31/2018 Common: 4,481,275,578 Preferred: A: 26.9806 B: 100,000,000 C: 150,000 *Right-click the rows below and select “Insert” to add rows as needed.

Each Share of Series A = 250 Shares of Common John G. Hule None West Berlin, NJ 2.5806 Series A 10% 2004 H.C. Wainwright Capital Raise Each Share of Series A = 250 Shares of Common Charles O’Brien None Boston, MA 1.4000 Series A 5% 2004 H.C. Wainwright Capital Raise Each Share of Series A = 250 Shares of Common Ward L. Snyder None Tucson, AZ 3.0000 Series A 11% 2004 H.C. Wainwright Capital Raise Each Share of Series A = 250 Shares of Common Mark D Schmidt Officer Durham, NC 44,000,000 Series B 44% Poison-Pill Voting Control Protection John W Ringo Officer Atlanta, GA 25,000,000 Series B 25% Poison-Pill Voting Control Protection David D Downing Officer Marietta, OH 31,000,000 Series B 31% Poison-Pill Voting Control Protection University of California - Santa Barbara Kevin Stewart Director of UCSB Office of Technology & Industry Alliances Santa Barbara, CA 75,000 Series C 50% 2006 Technology Transfer Agreement Each Share of Series C = $25.20 divided by the 10 day moving average closing price, then divided by 200 for 2010 200 to 1 reverse split Rensselaer Polytechnic Institute Tasha Sanford Office of Intellectual Property Optimization Troy, NY 75,000 Series C 50% 2006 Technology Transfer Agreement Each Share of Series C = $25.20 divided by the 10 day moving average closing price, then

Each Share of Series A = 250 Shares of Common John G. Hule None West Berlin, NJ 2.5806 Series A 10% 2004 H.C. Wainwright Capital Raise Each Share of Series A = 250 Shares of Common Charles O’Brien None Boston, MA 1.4000 Series A 5% 2004 H.C. Wainwright Capital Raise Each Share of Series A = 250 Shares of Common Ward L. Snyder None Tucson, AZ 3.0000 Series A 11% 2004 H.C. Wainwright Capital Raise Each Share of Series A = 250 Shares of Common Mark D Schmidt Officer Durham, NC 44,000,000 Series B 44% Poison-Pill Voting Control Protection John W Ringo Officer Atlanta, GA 25,000,000 Series B 25% Poison-Pill Voting Control Protection David D Downing Officer Marietta, OH 31,000,000 Series B 31% Poison-Pill Voting Control Protection University of California - Santa Barbara Kevin Stewart Director of UCSB Office of Technology & Industry Alliances Santa Barbara, CA 75,000 Series C 50% 2006 Technology Transfer Agreement Each Share of Series C = $25.20 divided by the 10 day moving average closing price, then divided by 200 for 2010 200 to 1 reverse split Rensselaer Polytechnic Institute Tasha Sanford Office of Intellectual Property Optimization Troy, NY 75,000 Series C 50% 2006 Technology Transfer Agreement Each Share of Series C = $25.20 divided by the 10 day moving average closing price, then

Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines Cyberlux Corporation 800 Park Offices Drive, Suite 3209 Research Triangle, NC 27709 984-363-6894 www.cyberlux.com info@cyberlux.com 3674 Annual Report For the Period Ending: December 31, 2020 (the “Reporting Period”) As of December 31, 2020, the number of shares outstanding of our Common Stock was: 4,481,275,578 As of September 30, 2020, the number of shares outstanding of our Common Stock was: 4,481,275,578 As of December 31, 2019, the number of shares outstanding of our Common Stock was: 4,481,275,578 Indicate by check mark whether the company is a shell company (as defined in Rule 405 of the Securities Act of 1933 and Rule 12b-2 of the Exchange Act of 1934): Yes: ☐ No: ☒ Indicate by check mark whether the company’s shell status has changed since the previous reporting period: Yes: ☐ No: ☒ Indicate by check mark whether a Change in Control1 of the company has occurred over this reporting period: Yes: ☐ No: ☒ 1) Name and address(es) of the issuer and its predecessors (if any) Cyberlux Corporation (the “Company”) was incorporated under the laws of the State of Nevada on May 17, 2000. Until December 31, 2004, the Company was a development stage enterprise as defined under Accounting Standards Codification 1 “Change in Control” shall mean any events resulting in: (i) Any “person” (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becoming the “beneficial owner” (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company’s then outstanding voting securities; (ii) The consummation of the sale or disposition by the Company of all or substantially all of the C ompany’s assets; (iii) A change in the composition of the Board occurring within a two (2) -year period, as a result of which fewer than a majority of the directors are directors immediately prior to such change; or (iv) The consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation.

10) Issuer Certification Principal Executive Officer: The issuer shall include certifications by the chief executive officer and chief financial officer of the issuer (or any other persons with different titles but having the same responsibilities) in each Annual Report or Annual Report. The certifications shall follow the format below: I, Mark D Schmidt certify that: 1. I have reviewed this Annual disclosure statement of Cyberlux Corporation; 2. Based on my knowledge, this disclosure statement does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this disclosure statement; and 3. Based on my knowledge, the financial statements, and other financial information included or incorporated by reference in this disclosure statement, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this disclosure statement. December 6, 2022 /s/ Mark D Schmidt Principal Financial Officer: I, David D Downing certify that: 1. I have reviewed this Annual disclosure statement of Cyberlux Corporation; 2. Based on my knowledge, this disclosure statement does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this disclosure statement; and 3. Based on my knowledge, the financial statements, and other financial information included or incorporated by reference in this disclosure statement, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this disclosure statement. December 6, 2020 /s/ David D Downing

10) Issuer Certification Principal Executive Officer: The issuer shall include certifications by the chief executive officer and chief financial officer of the issuer (or any other persons with different titles but having the same responsibilities) in each Annual Report or Annual Report. The certifications shall follow the format below: I, Mark D Schmidt certify that: 1. I have reviewed this Annual disclosure statement of Cyberlux Corporation; 2. Based on my knowledge, this disclosure statement does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this disclosure statement; and 3. Based on my knowledge, the financial statements, and other financial information included or incorporated by reference in this disclosure statement, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this disclosure statement. December 6, 2022 /s/ Mark D Schmidt Principal Financial Officer: I, David D Downing certify that: 1. I have reviewed this Annual disclosure statement of Cyberlux Corporation; 2. Based on my knowledge, this disclosure statement does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this disclosure statement; and 3. Based on my knowledge, the financial statements, and other financial information included or incorporated by reference in this disclosure statement, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this disclosure statement. December 6, 2020 /s/ David D Downing

Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines Cyberlux Corporation 800 Park Offices Drive, Suite 3209 Research Triangle, NC 27709 984-363-6894 www.cyberlux.com info@cyberlux.com 3674 Annual Report For the Period Ending: December 31, 2020 (the “Reporting Period”) As of December 31, 2020, the number of shares outstanding of our Common Stock was: 4,481,275,578 As of September 30, 2020, the number of shares outstanding of our Common Stock was: 4,481,275,578 As of December 31, 2019, the number of shares outstanding of our Common Stock was: 4,481,275,578 Indicate by check mark whether the company is a shell company (as defined in Rule 405 of the Securities Act of 1933 and Rule 12b-2 of the Exchange Act of 1934): Yes: ☐ No: ☒ Indicate by check mark whether the company’s shell status has changed since the previous reporting period: Yes: ☐ No: ☒ Indicate by check mark whether a Change in Control1 of the company has occurred over this reporting period: Yes: ☐ No: ☒ 1) Name and address(es) of the issuer and its predecessors (if any) Cyberlux Corporation (the “Company”) was incorporated under the laws of the State of Nevada on May 17, 2000. Until December 31, 2004, the Company was a development stage enterprise as defined under Accounting Standards Codification 1 “Change in Control” shall mean any events resulting in: (i) Any “person” (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becoming the “beneficial owner” (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company’s then outstanding voting securities; (ii) The consummation of the sale or disposition by the Company of all or substantially all of the C ompany’s assets; (iii) A change in the composition of the Board occurring within a two (2) -year period, as a result of which fewer than a majority of the directors are directors immediately prior to such change; or (iv) The consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation.